Company Overview of BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Founded in 1993
41 44 267 67 00
41 44 267 67 01
Key Executives for BB Biotech AG
BB Biotech AG Key Developments
Similar Private Companies By Industry
|“The Lantern” Research Sagl||Europe|
|A&a Bull And Bear||Europe|
|AAA Corporate Finance Advisers AG||Europe|
|Abrir Capital Advisors AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact BB Biotech AG, please visit www.bellevue.ch/cms/lang/en/home/bellevue_asset_management/investment_products/CH0038389992/CH003838. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.